| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/22/2011 | CN1984905B Constrained himbacine analogs as thrombin receptor antagonists |
| 06/22/2011 | CN1964723B Use of fine grain of macromolecule in preparing transparent tissue visualizing agent |
| 06/22/2011 | CN1903364B Medicine composition containing inhibitor of angiotonase and phenoxy acid compounds |
| 06/22/2011 | CN1900076B Tetrahydro proto-berberine compounds, and their preparing method and use |
| 06/22/2011 | CN1898244B Triazole derivatives as vasopressin antagonists |
| 06/22/2011 | CN1894246B Novel crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-n-hydroxyethyl-imidazo[1,2-a]pyridine-6-carboxamide mesylate salt |
| 06/22/2011 | CN1887309B Extraction of effective red sage components for preventing and treating osteoporosis and depression |
| 06/22/2011 | CN1874778B Pharmaceutical formulation comprising a pyrimidine-A-one derivative coated with an enteric polymer |
| 06/22/2011 | CN1867565B Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes |
| 06/22/2011 | CN1845734B Benzimidazole derivatives and their use as protein kinases inhibitors |
| 06/22/2011 | CN1809570B [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 06/22/2011 | CN1701073B Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 06/22/2011 | CN1596314B Method of determining a chemotherapeutic regimen based on ercc1 and ts expression |
| 06/22/2011 | CN1447819B Human CYR 61 |
| 06/22/2011 | CN102105485A Selective caspase inhibitors and uses thereof |
| 06/22/2011 | CN102105484A Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring |
| 06/22/2011 | CN102105483A Universal methylation profiling methods |
| 06/22/2011 | CN102105475A Spiroaminodihydrothiazine derivatives |
| 06/22/2011 | CN102105474A Purine PI3K inhibitor compounds and methods of use |
| 06/22/2011 | CN102105473A Tricyclic nitrogen containing compounds and their use as antibacterials |
| 06/22/2011 | CN102105472A Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 06/22/2011 | CN102105471A Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 06/22/2011 | CN102105470A Anti-infective compounds |
| 06/22/2011 | CN102105469A Heterocyclic urea derivatives for the treatment of bacterial infections |
| 06/22/2011 | CN102105468A Heterocyclic urea derivatives and methods of use thereof |
| 06/22/2011 | CN102105467A Tricyclic alkylaminomethyloxazolidinone derivatives |
| 06/22/2011 | CN102105466A Isoxazole derivatives and their use as metabotropic glutamate receptor potentiators |
| 06/22/2011 | CN102105465A Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof |
| 06/22/2011 | CN102105463A Bicyclic compounds having activity at the CXCR4 receptor |
| 06/22/2011 | CN102105462A Amidophenoxyindazoles useful as inhibitors of C-MET |
| 06/22/2011 | CN102105459A 3,4-diarylpyrazoles as protein kinase inhibitors |
| 06/22/2011 | CN102105458A 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2-pyridinyl-2-alkyl-prolinamide as NK1 receptor antagonists |
| 06/22/2011 | CN102105457A 5-demethoxyfumagillol and derivatives thereof |
| 06/22/2011 | CN102105456A Aryl-sulphonamidic dimers as metalloproteases inhibitors |
| 06/22/2011 | CN102105453A Therapeutic agent for chronic renal failure |
| 06/22/2011 | CN102105452A Substituted carbinol compound having cyclic linker |
| 06/22/2011 | CN102105451A Glucokinase activators |
| 06/22/2011 | CN102105449A Arylsulfonamide compounds, compositions and methods of use |
| 06/22/2011 | CN102105448A Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states |
| 06/22/2011 | CN102105437A Adamantyl diamide derivatives and uses of same |
| 06/22/2011 | CN102105436A Fatty acid derivatives for oral administration endowed with high paia- tability |
| 06/22/2011 | CN102105427A Atovaquone with a particle size diameter range (D90) of greater than 3 [mu]m to about 10 [mu]m |
| 06/22/2011 | CN102105171A Modified release niacin formulations |
| 06/22/2011 | CN102105169A Pharmaceutical compositions for treatment of parkinson's disease |
| 06/22/2011 | CN102105168A Therapeutic agent for migraine |
| 06/22/2011 | CN102105167A Prophylactic or therapeutic agent for axial myopia |
| 06/22/2011 | CN102105157A A conjugate of a polymer, an anti-angiogenesis agent and a targeting moiety, and uses thereof in the treatment of bone related angiogenesis conditions |
| 06/22/2011 | CN102105156A Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases |
| 06/22/2011 | CN102105155A Polysaccharides extract from dendrobium for treating allergic diseases |
| 06/22/2011 | CN102105154A Preparation for oral administration comprising water-extracted chondroitin sulfate and quercetin glycoside |
| 06/22/2011 | CN102105153A Method for treating hyperuricemia employing an SGLT2 inhibitor and composition containing same |
| 06/22/2011 | CN102105152A Therapeutic combination comprising a cdks inhibitor and an antineoplastic agent |
| 06/22/2011 | CN102105151A Use of a CDK inhibitor for the treatment of glioma |
| 06/22/2011 | CN102105150A Phosphorous derivatives as kinase inhibitors |
| 06/22/2011 | CN102105149A Substituted carbamate derivatives as modulators of corticotropin-releasing factor receptor activity |
| 06/22/2011 | CN102105148A Therapeutic combination comprising an AURORA kinase inhibitor and antiproliferative agents |
| 06/22/2011 | CN102105147A Therapeutic combination comprising an AURORA kinase inhibitor and an antineoplastic agent |
| 06/22/2011 | CN102105146A Methods for treating injury associated with exposure to an alkylating species |
| 06/22/2011 | CN102105145A Treatment for diabetes in patients inappropriate for metformin therapy |
| 06/22/2011 | CN102105144A Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation |
| 06/22/2011 | CN102105143A Stable pharmaceutical composition containing tranexamic acid and ascorbic acid |
| 06/22/2011 | CN102105142A Compositions for treating rosacea comprising chitosan and a dicarboxylic acid |
| 06/22/2011 | CN102105138A Pharmaceutical compositions comprising 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
| 06/22/2011 | CN102105135A Modified drugs for use in liposomal nanoparticles |
| 06/22/2011 | CN102105134A Stable injectable oil-in-water docetaxel nanoemulsion |
| 06/22/2011 | CN102105133A Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
| 06/22/2011 | CN102105071A Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders |
| 06/22/2011 | CN102105059A Methods and compositions for sleep disorders and other disorders |
| 06/22/2011 | CN102105055A 抗微生物组合物和使用方法 Antimicrobial compositions and methods of use |
| 06/22/2011 | CN102105054A Method of treating traumatic brain injury |
| 06/22/2011 | CN102102114A Preparation of pregabalin and related compounds |
| 06/22/2011 | CN102101880A Preparation method and application of radix astragali saponin |
| 06/22/2011 | CN102101879A Arenobufagin space isomer compound and preparation and application thereof |
| 06/22/2011 | CN102101878A Hellebore petunidin space isomer compound and preparation and application thereof |
| 06/22/2011 | CN102101867A Thiazinogeldanamycin and preparation method and use thereof |
| 06/22/2011 | CN102101866A Halogenated derivatives of staurosporine, and preparation method thereof and use thereof |
| 06/22/2011 | CN102101865A Crystal form of carbostyril compound hydrochlorides |
| 06/22/2011 | CN102101864A Trigonolactone A-D and medicinal composition, preparation method and application thereof |
| 06/22/2011 | CN102101863A Novel epoxy thiazone compounds and preparation method and application thereof |
| 06/22/2011 | CN102101859A Quinolone carboxylic acid derivatives and application thereof |
| 06/22/2011 | CN102101858A Preparation method of ramosetron derivatives and applications thereof |
| 06/22/2011 | CN102101857A 1-(4-chlorine-2H-benzo[b]thiapyran-3-formaldehyde) (thio)semicarbazone derivative serving as antifungal agent |
| 06/22/2011 | CN102101854A Benzomacrolide compounds having pancrelipase inhibiting activity and synthesis method and use thereof |
| 06/22/2011 | CN102101836A New crystal form of S-oxiracetam and preparation method thereof |
| 06/22/2011 | CN102101825A PTP1B (Protein Tyrosine Phosphatase 1B) inhibitor, and synthesis and application thereof |
| 06/22/2011 | CN102100915A Chlorambucil multi-targeting medicine carrying system and preparation method and application thereof |
| 06/22/2011 | CN102100914A Artificial oil body carrier for targeted therapy of mastocarcinoma as well as preparation method and application thereof |
| 06/22/2011 | CN102100913A Target spot and medicine for treating cerebral injury |
| 06/22/2011 | CN102100907A Composition of oral pharmacologic active agent |
| 06/22/2011 | CN102100905A Novel compound antimicrobial preparation |
| 06/22/2011 | CN102100892A Preparation technology and production method of integrated Xiaojianzhong decoction novel dosage form |
| 06/22/2011 | CN102100871A Chinese medicinal preparation for treating insomnia and amnesia |
| 06/22/2011 | CN102100867A Musk rheumatism bone paste |
| 06/22/2011 | CN102100859A Chinese medicinal composition with effects of removing chloasma and relaxing bowels and preparation method thereof |
| 06/22/2011 | CN102100850A Quality control method for refined fructus forsythiae antidotal tablets |
| 06/22/2011 | CN102100827A External-use ointment for treating hemorrhoids |
| 06/22/2011 | CN102100822A New application of pure safflower oil |
| 06/22/2011 | CN102100821A Medicinal cigarette external surface liniment for treating hemorrhoids, and preparation method and application thereof |
| 06/22/2011 | CN102100807A Chinese medicine composition for regulating qi, widening chest and relieving pain as well as detection method thereof |
| 06/22/2011 | CN102100805A Composition for relieving physical fatigue and enhancing immunologic function, preparation method thereof and application thereof |